Humanwell Healthcare (Group) Co.,Ltd. (SHA:600079)
China flag China · Delayed Price · Currency is CNY
19.13
-0.32 (-1.65%)
Oct 30, 2026, 3:00 PM CST

SHA:600079 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
2,5821,8551,3302,1342,4841,317
Depreciation & Amortization
942.491,0081,025811.99748.05679.34
Other Amortization
100.7934.9617.5413.4215.1815.63
Loss (Gain) From Sale of Assets
-55.57-55.574.471.0838.76-26.06
Asset Writedown & Restructuring Costs
397.32397.3232353.9384.4849.85
Loss (Gain) From Sale of Investments
-126.85-126.85-197.35-356.95-882.3-324.12
Provision & Write-off of Bad Debts
49.9649.96124.7672.5557.5248.15
Other Operating Activities
388.26981.6967.211,094764.771,146
Change in Accounts Receivable
-978.69-978.69-764.55-1,070-916.36-789.27
Change in Inventory
143.72143.72-0.46-200.36-360.79-486.24
Change in Accounts Payable
-760.66-760.66-679.48-643.33151.96515.47
Change in Other Net Operating Assets
--13.2743.18105.8343.94
Operating Cash Flow
2,6522,5192,1641,9672,4412,179
Operating Cash Flow Growth
14.32%16.38%10.02%-19.41%12.04%4.26%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-545.21-732.65-1,021-1,958-3,113-1,703
Sale of Property, Plant & Equipment
23.617.3336.1845.0397.6484.29
Cash Acquisitions
---53.04---36.66
Divestitures
14.75171.66220.6220.97286.5234.97
Investment in Securities
1,20380.5949.36559.83,451202.53
Other Investing Activities
40.7982.725.8107.81505.45-2.3
Investing Cash Flow
736.51-390.37-742.03-1,2251,227-1,420

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-332.75494.781,1721,577721.22
Long-Term Debt Issued
-10,5889,3489,4699,47610,758
Total Debt Issued
6,91310,9209,84310,64111,05211,479
Short-Term Debt Repaid
--399.67-449.72-1,721-2,097-1,370
Long-Term Debt Repaid
--11,051-9,461-10,173-12,104-11,490
Lease Payments
-22.19-22.19-20.49-35.63-18.05-19.65
Total Debt Repaid
-7,918-11,451-9,910-11,894-14,201-12,860
Net Debt Issued (Repaid)
-1,005-530.24-67.5-1,253-3,148-1,381
Issuance of Common Stock
----9.971,270
Repurchase of Common Stock
---1.64-3.89-4.63-
Common Dividends Paid
-1,002-1,056-1,269-587.69-612.92-665.55
Other Financing Activities
651.45-215.25-159.54-260.67-488.88-138.11
Financing Cash Flow
-1,356-1,801-1,498-2,106-4,245-914

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-86.78-0.69-23.8716.348.45-24.96
Net Cash Flow
1,946326.57-99.62-1,347-528.63-180.35

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
2,1061,7861,1438.93-672.27475.78
Free Cash Flow Growth
43.77%56.22%12703.33%---52.03%
Free Cash Flow Margin
8.60%7.45%4.50%0.04%-3.01%2.31%
Free Cash Flow Per Share
1.301.100.700.01-0.420.30
Levered Free Cash Flow
1,8011,5091,088-1,760-1,365244.27
Unlevered Free Cash Flow
1,8361,6791,308-1,539-1,067620.61
Free Cash Flow After Leases
2,0841,7641,123-26.7-690.32456.13

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
1,9691,7781,8721,7611,6911,203
Change in Working Capital
-1,626-1,626-1,431-1,857-869.51-727.17